Deep learning auto-segmentation has greatly advanced contouring in radiotherapy. However, quality assurance remains necessary due to performance fluctuation among individual patients. This manual process reintroduces variability and partially reduces...
BACKGROUND: Accurate preoperative risk stratification for patients with head and neck (H&N) cancer remained a critical challenge, as long-term survival rates are poor despite aggressive multimodality treatment. While deep learning models showed promi...
BACKGROUND: Head and neck cancer (HNC) survivors face profound functional and quality-of-life deficits due to disease- and treatment-related sequelae, ranging from mild fatigue to debilitating dysphagia. Wearable technology, by monitoring biometric d...
This study aimed to evaluate the use of deep learning techniques to produce measured attenuation-corrected (MAC) images from non-attenuation-corrected (NAC) F-FDG PET images, focusing on head and neck imaging. A Residual Network (ResNet) was used to ...
BACKGROUND AND PURPOSE: Radiotherapy (RT) of head and neck cancer can cause severe toxicities. Early identification of individuals at risk could enable personalized treatment. This study evaluated whether convolutional neural networks (CNNs) applied ...
The Cochrane database of systematic reviews
Sep 10, 2025
BACKGROUND: Radiotherapy is the mainstay of treatment for head and neck cancer (HNC) but may induce various side effects on surrounding normal tissues. To reach an optimal balance between tumour control and toxicity prevention, normal tissue complica...
BACKGROUND AND PURPOSE: Delta biomarkers that reflect changes in tumour burden over time can support personalised follow-up in head and neck cancer. However, their clinical use can be limited by the need for manual image segmentation. This study exte...
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Aug 20, 2025
PURPOSE: This study aims to explore the role of patient-reported cancer care coordination in explaining depression among head and neck (HNC) cancer survivors.
Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignancy with a low five-year survival rate, emphasising the urgent need for effective prognostic biomarkers to guide patient stratification and personalised treatment. Plasma cells (PCs)...
Head and Neck Squamous Cell Carcinoma (HNSCC) is the seventh most prevalent cancer worldwide and is classified as human papillomavirus (HPV) positive or negative. Substantial heterogeneity has been observed in the two groups, posing a significant cli...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.